Literature DB >> 22623777

The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domains.

Winnie M Chan1, Brian M Ward.   

Abstract

There are two mechanisms for the incorporation of B5 into the envelope of extracellular virions produced by orthopoxviruses, one that requires A33 and one that does not. We have hypothesized that the A33-dependent mechanism requires a direct interaction between A33 and B5. In this study, chimeric constructs of A33 and B5/B5-green fluorescent protein (GFP) were used to show that the two proteins interact through their lumenal domains and that the coiled-coil domain of B5 is sufficient for an interaction with A33. Furthermore, our experiments reveal that a transmembrane domain, not necessarily its own, is requisite for the lumenal domain of B5 to interact with A33. In contrast, the lumenal domain of A33 is sufficient for interaction with B5. Furthermore, the lumenal domain of A33 is sufficient to restore the proper localization of B5-GFP in infected cells. Taken together, our results demonstrate that the lumenal domains of A33 and B5 interact and that the interaction is required for the incorporation of B5-GFP into extracellular virions, whereas the incorporation of A33 is independent of B5. These results suggest that viral protein incorporation into extracellular virions is an active process requiring specific protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22623777      PMCID: PMC3421693          DOI: 10.1128/JVI.00249-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.

Authors:  W H Zhang; D Wilcock; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.

Authors:  J W Hooper; D M Custer; C S Schmaljohn; A L Schmaljohn
Journal:  Virology       Date:  2000-01-20       Impact factor: 3.616

5.  Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus.

Authors:  J Rietdorf; A Ploubidou; I Reckmann; A Holmström; F Frischknecht; M Zettl; T Zimmermann; M Way
Journal:  Nat Cell Biol       Date:  2001-11       Impact factor: 28.824

6.  Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  The vaccinia virus A33R protein provides a chaperone function for viral membrane localization and tyrosine phosphorylation of the A36R protein.

Authors:  E J Wolffe; A S Weisberg; B Moss
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles.

Authors:  H van Eijl; M Hollinshead; G L Smith
Journal:  Virology       Date:  2000-05-25       Impact factor: 3.616

9.  Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein.

Authors:  María M Geada; Inmaculada Galindo; María M Lorenzo; Beatriz Perdiguero; Rafael Blasco
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

10.  Vaccinia virus utilizes microtubules for movement to the cell surface.

Authors:  M Hollinshead; G Rodger; H Van Eijl; M Law; R Hollinshead; D J Vaux; G L Smith
Journal:  J Cell Biol       Date:  2001-07-23       Impact factor: 10.539

View more
  6 in total

1.  Increased interaction between vaccinia virus proteins A33 and B5 is detrimental to infectious extracellular enveloped virion production.

Authors:  Winnie M Chan; Brian M Ward
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  The Ectodomain of the Vaccinia Virus Glycoprotein A34 Is Required for Cell Binding by Extracellular Virions and Contains a Large Region Capable of Interaction with Glycoprotein B5.

Authors:  Stephanie R Monticelli; Amalia K Earley; Jessica Tate; Brian M Ward
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

3.  The Molluscum Contagiosum Gene MC021L Partially Compensates for the Loss of Its Vaccinia Virus Homolog, F13L.

Authors:  Stephanie R Monticelli; Peter Bryk; Brian M Ward
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

4.  Partial Deletion of Glycoprotein B5R Enhances Vaccinia Virus Neutralization Escape while Preserving Oncolytic Function.

Authors:  Motomu Nakatake; Hajime Kurosaki; Nozomi Kuwano; Kosuke Horita; Mai Ito; Hiromichi Kono; Tomotaka Okamura; Kosei Hasegawa; Yasuhiro Yasutomi; Takafumi Nakamura
Journal:  Mol Ther Oncolytics       Date:  2019-05-21       Impact factor: 7.200

5.  A36-dependent actin filament nucleation promotes release of vaccinia virus.

Authors:  Jacquelyn Horsington; Helena Lynn; Lynne Turnbull; Delfine Cheng; Filip Braet; Russell J Diefenbach; Cynthia B Whitchurch; Guna Karupiah; Timothy P Newsome
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

Review 6.  Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors.

Authors:  Sally Al Ali; Sara Baldanta; Mercedes Fernández-Escobar; Susana Guerra
Journal:  Viruses       Date:  2016-05-21       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.